nodes	percent_of_prediction	percent_of_DWPC	metapath
Pasireotide—Pituitary-dependent Cushing's syndrome—Methylprednisolone—multiple sclerosis	0.0429	0.152	CcSEcCtD
Pasireotide—SSTR5—brainstem—multiple sclerosis	0.0247	0.113	CbGeAlD
Pasireotide—SSTR3—brainstem—multiple sclerosis	0.0237	0.108	CbGeAlD
Pasireotide—SSTR1—brainstem—multiple sclerosis	0.0187	0.0854	CbGeAlD
Pasireotide—SSTR2—brainstem—multiple sclerosis	0.0159	0.0726	CbGeAlD
Pasireotide—SSTR3—nervous system—multiple sclerosis	0.0124	0.0566	CbGeAlD
Pasireotide—SSTR5—cerebellum—multiple sclerosis	0.0122	0.0556	CbGeAlD
Pasireotide—SSTR3—central nervous system—multiple sclerosis	0.0119	0.0545	CbGeAlD
Pasireotide—SSTR1—midbrain—multiple sclerosis	0.0119	0.0544	CbGeAlD
Pasireotide—SSTR3—cerebellum—multiple sclerosis	0.0117	0.0533	CbGeAlD
Pasireotide—SSTR1—nervous system—multiple sclerosis	0.0098	0.0447	CbGeAlD
Pasireotide—SSTR3—brain—multiple sclerosis	0.00948	0.0433	CbGeAlD
Pasireotide—SSTR1—central nervous system—multiple sclerosis	0.00944	0.0431	CbGeAlD
Pasireotide—SSTR1—cerebellum—multiple sclerosis	0.00922	0.0421	CbGeAlD
Pasireotide—Gamma-glutamyltransferase increased—Fingolimod—multiple sclerosis	0.00891	0.0315	CcSEcCtD
Pasireotide—SSTR2—nervous system—multiple sclerosis	0.00833	0.038	CbGeAlD
Pasireotide—SSTR2—central nervous system—multiple sclerosis	0.00802	0.0366	CbGeAlD
Pasireotide—SSTR2—cerebellum—multiple sclerosis	0.00784	0.0358	CbGeAlD
Pasireotide—Adrenal insufficiency—Prednisone—multiple sclerosis	0.00777	0.0275	CcSEcCtD
Pasireotide—SSTR1—brain—multiple sclerosis	0.00749	0.0342	CbGeAlD
Pasireotide—SSTR2—brain—multiple sclerosis	0.00637	0.0291	CbGeAlD
Pasireotide—Sinus bradycardia—Mitoxantrone—multiple sclerosis	0.00557	0.0197	CcSEcCtD
Pasireotide—Blood glucose increased—Mitoxantrone—multiple sclerosis	0.00534	0.0189	CcSEcCtD
Pasireotide—Aspartate aminotransferase increased—Fingolimod—multiple sclerosis	0.00479	0.017	CcSEcCtD
Pasireotide—Alanine aminotransferase increased—Fingolimod—multiple sclerosis	0.00469	0.0166	CcSEcCtD
Pasireotide—Influenza—Fingolimod—multiple sclerosis	0.0046	0.0163	CcSEcCtD
Pasireotide—Injection site reaction—Cladribine—multiple sclerosis	0.00413	0.0146	CcSEcCtD
Pasireotide—Gamma-glutamyltransferase increased—Mitoxantrone—multiple sclerosis	0.00332	0.0118	CcSEcCtD
Pasireotide—Alopecia—Fingolimod—multiple sclerosis	0.00325	0.0115	CcSEcCtD
Pasireotide—Back pain—Fingolimod—multiple sclerosis	0.0031	0.011	CcSEcCtD
Pasireotide—Pain in extremity—Cladribine—multiple sclerosis	0.00302	0.0107	CcSEcCtD
Pasireotide—Hypertension—Fingolimod—multiple sclerosis	0.00277	0.00979	CcSEcCtD
Pasireotide—Hypotension—Fingolimod—multiple sclerosis	0.00244	0.00865	CcSEcCtD
Pasireotide—Fatigue—Fingolimod—multiple sclerosis	0.00225	0.00798	CcSEcCtD
Pasireotide—Oedema peripheral—Cladribine—multiple sclerosis	0.00206	0.00728	CcSEcCtD
Pasireotide—Asthenia—Fingolimod—multiple sclerosis	0.00188	0.00664	CcSEcCtD
Pasireotide—Diabetes mellitus—Prednisolone—multiple sclerosis	0.00187	0.00662	CcSEcCtD
Pasireotide—Pruritus—Fingolimod—multiple sclerosis	0.00185	0.00655	CcSEcCtD
Pasireotide—Alopecia—Cladribine—multiple sclerosis	0.00184	0.00653	CcSEcCtD
Pasireotide—Abdominal pain upper—Mitoxantrone—multiple sclerosis	0.00181	0.00641	CcSEcCtD
Pasireotide—Hypokalaemia—Mitoxantrone—multiple sclerosis	0.0018	0.00639	CcSEcCtD
Pasireotide—Diarrhoea—Fingolimod—multiple sclerosis	0.00179	0.00633	CcSEcCtD
Pasireotide—Aspartate aminotransferase increased—Mitoxantrone—multiple sclerosis	0.00178	0.00632	CcSEcCtD
Pasireotide—Back pain—Cladribine—multiple sclerosis	0.00176	0.00622	CcSEcCtD
Pasireotide—Alanine aminotransferase increased—Mitoxantrone—multiple sclerosis	0.00175	0.00619	CcSEcCtD
Pasireotide—Dizziness—Fingolimod—multiple sclerosis	0.00173	0.00612	CcSEcCtD
Pasireotide—Hypercholesterolaemia—Prednisone—multiple sclerosis	0.00172	0.00609	CcSEcCtD
Pasireotide—Diabetes mellitus—Triamcinolone—multiple sclerosis	0.00172	0.00609	CcSEcCtD
Pasireotide—Diabetes mellitus—Methylprednisolone—multiple sclerosis	0.00172	0.00607	CcSEcCtD
Pasireotide—Anaemia—Cladribine—multiple sclerosis	0.00168	0.00594	CcSEcCtD
Pasireotide—Headache—Fingolimod—multiple sclerosis	0.00164	0.0058	CcSEcCtD
Pasireotide—Diabetes mellitus—Dexamethasone—multiple sclerosis	0.00156	0.00552	CcSEcCtD
Pasireotide—Diabetes mellitus—Betamethasone—multiple sclerosis	0.00156	0.00552	CcSEcCtD
Pasireotide—Myalgia—Cladribine—multiple sclerosis	0.00155	0.00547	CcSEcCtD
Pasireotide—Arthralgia—Cladribine—multiple sclerosis	0.00155	0.00547	CcSEcCtD
Pasireotide—Hyperglycaemia—Mitoxantrone—multiple sclerosis	0.00155	0.00547	CcSEcCtD
Pasireotide—Anxiety—Cladribine—multiple sclerosis	0.00154	0.00546	CcSEcCtD
Pasireotide—Alopecia—Azathioprine—multiple sclerosis	0.0015	0.00531	CcSEcCtD
Pasireotide—Dry skin—Prednisolone—multiple sclerosis	0.00149	0.00528	CcSEcCtD
Pasireotide—Abdominal distension—Prednisolone—multiple sclerosis	0.00141	0.00501	CcSEcCtD
Pasireotide—Hypotension—Cladribine—multiple sclerosis	0.00139	0.0049	CcSEcCtD
Pasireotide—Anaemia—Azathioprine—multiple sclerosis	0.00136	0.00483	CcSEcCtD
Pasireotide—Diabetes mellitus—Prednisone—multiple sclerosis	0.00136	0.00481	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Cladribine—multiple sclerosis	0.00135	0.00478	CcSEcCtD
Pasireotide—Insomnia—Cladribine—multiple sclerosis	0.00134	0.00475	CcSEcCtD
Pasireotide—Alanine aminotransferase increased—Methylprednisolone—multiple sclerosis	0.00132	0.00466	CcSEcCtD
Pasireotide—Abdominal distension—Triamcinolone—multiple sclerosis	0.0013	0.00461	CcSEcCtD
Pasireotide—Abdominal distension—Methylprednisolone—multiple sclerosis	0.0013	0.0046	CcSEcCtD
Pasireotide—Influenza—Triamcinolone—multiple sclerosis	0.00129	0.00458	CcSEcCtD
Pasireotide—Decreased appetite—Cladribine—multiple sclerosis	0.00129	0.00456	CcSEcCtD
Pasireotide—Fatigue—Cladribine—multiple sclerosis	0.00128	0.00452	CcSEcCtD
Pasireotide—Constipation—Cladribine—multiple sclerosis	0.00127	0.00449	CcSEcCtD
Pasireotide—Arthralgia—Azathioprine—multiple sclerosis	0.00126	0.00445	CcSEcCtD
Pasireotide—Myalgia—Azathioprine—multiple sclerosis	0.00126	0.00445	CcSEcCtD
Pasireotide—Dry skin—Betamethasone—multiple sclerosis	0.00124	0.0044	CcSEcCtD
Pasireotide—Dry skin—Dexamethasone—multiple sclerosis	0.00124	0.0044	CcSEcCtD
Pasireotide—Hypokalaemia—Dexamethasone—multiple sclerosis	0.00123	0.00437	CcSEcCtD
Pasireotide—Hypokalaemia—Betamethasone—multiple sclerosis	0.00123	0.00437	CcSEcCtD
Pasireotide—Gastrointestinal pain—Cladribine—multiple sclerosis	0.00121	0.00429	CcSEcCtD
Pasireotide—Alopecia—Mitoxantrone—multiple sclerosis	0.00121	0.00429	CcSEcCtD
Pasireotide—Abdominal pain—Cladribine—multiple sclerosis	0.00117	0.00415	CcSEcCtD
Pasireotide—Back pain—Mitoxantrone—multiple sclerosis	0.00115	0.00409	CcSEcCtD
Pasireotide—Diabetes mellitus—Methotrexate—multiple sclerosis	0.00114	0.00402	CcSEcCtD
Pasireotide—Hypotension—Azathioprine—multiple sclerosis	0.00113	0.00399	CcSEcCtD
Pasireotide—Anaemia—Mitoxantrone—multiple sclerosis	0.0011	0.00391	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Azathioprine—multiple sclerosis	0.0011	0.00389	CcSEcCtD
Pasireotide—Dry skin—Prednisone—multiple sclerosis	0.00108	0.00384	CcSEcCtD
Pasireotide—Hypokalaemia—Prednisone—multiple sclerosis	0.00108	0.00381	CcSEcCtD
Pasireotide—Asthenia—Cladribine—multiple sclerosis	0.00106	0.00377	CcSEcCtD
Pasireotide—Hyperglycaemia—Betamethasone—multiple sclerosis	0.00106	0.00375	CcSEcCtD
Pasireotide—Hyperglycaemia—Dexamethasone—multiple sclerosis	0.00106	0.00375	CcSEcCtD
Pasireotide—Pruritus—Cladribine—multiple sclerosis	0.00105	0.00371	CcSEcCtD
Pasireotide—Alanine aminotransferase increased—Prednisone—multiple sclerosis	0.00104	0.00369	CcSEcCtD
Pasireotide—Hypertension—Mitoxantrone—multiple sclerosis	0.00103	0.00365	CcSEcCtD
Pasireotide—Abdominal distension—Prednisone—multiple sclerosis	0.00103	0.00364	CcSEcCtD
Pasireotide—Arthralgia—Mitoxantrone—multiple sclerosis	0.00102	0.0036	CcSEcCtD
Pasireotide—Myalgia—Mitoxantrone—multiple sclerosis	0.00102	0.0036	CcSEcCtD
Pasireotide—Diarrhoea—Cladribine—multiple sclerosis	0.00101	0.00359	CcSEcCtD
Pasireotide—Anxiety—Mitoxantrone—multiple sclerosis	0.00101	0.00359	CcSEcCtD
Pasireotide—Gastrointestinal pain—Azathioprine—multiple sclerosis	0.000985	0.00349	CcSEcCtD
Pasireotide—Dizziness—Cladribine—multiple sclerosis	0.00098	0.00347	CcSEcCtD
Pasireotide—Abdominal pain—Azathioprine—multiple sclerosis	0.000953	0.00337	CcSEcCtD
Pasireotide—Vomiting—Cladribine—multiple sclerosis	0.000942	0.00334	CcSEcCtD
Pasireotide—Headache—Cladribine—multiple sclerosis	0.000929	0.00329	CcSEcCtD
Pasireotide—Hyperglycaemia—Prednisone—multiple sclerosis	0.000921	0.00326	CcSEcCtD
Pasireotide—Hypotension—Mitoxantrone—multiple sclerosis	0.00091	0.00322	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Mitoxantrone—multiple sclerosis	0.000888	0.00314	CcSEcCtD
Pasireotide—Nausea—Cladribine—multiple sclerosis	0.00088	0.00312	CcSEcCtD
Pasireotide—Vertigo—Prednisolone—multiple sclerosis	0.00088	0.00312	CcSEcCtD
Pasireotide—Back pain—Triamcinolone—multiple sclerosis	0.000871	0.00308	CcSEcCtD
Pasireotide—Decreased appetite—Mitoxantrone—multiple sclerosis	0.000847	0.003	CcSEcCtD
Pasireotide—Hypertension—Prednisolone—multiple sclerosis	0.000846	0.00299	CcSEcCtD
Pasireotide—Fatigue—Mitoxantrone—multiple sclerosis	0.00084	0.00297	CcSEcCtD
Pasireotide—Constipation—Mitoxantrone—multiple sclerosis	0.000833	0.00295	CcSEcCtD
Pasireotide—Alopecia—Betamethasone—multiple sclerosis	0.00083	0.00294	CcSEcCtD
Pasireotide—Alopecia—Dexamethasone—multiple sclerosis	0.00083	0.00294	CcSEcCtD
Pasireotide—Diarrhoea—Azathioprine—multiple sclerosis	0.000825	0.00292	CcSEcCtD
Pasireotide—Vertigo—Triamcinolone—multiple sclerosis	0.000809	0.00286	CcSEcCtD
Pasireotide—Vertigo—Methylprednisolone—multiple sclerosis	0.000807	0.00286	CcSEcCtD
Pasireotide—Dizziness—Azathioprine—multiple sclerosis	0.000797	0.00282	CcSEcCtD
Pasireotide—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.000797	0.00282	CcSEcCtD
Pasireotide—Hypertension—Triamcinolone—multiple sclerosis	0.000778	0.00275	CcSEcCtD
Pasireotide—Hypertension—Methylprednisolone—multiple sclerosis	0.000776	0.00275	CcSEcCtD
Pasireotide—Abdominal pain—Mitoxantrone—multiple sclerosis	0.00077	0.00273	CcSEcCtD
Pasireotide—Myalgia—Triamcinolone—multiple sclerosis	0.000767	0.00271	CcSEcCtD
Pasireotide—Vomiting—Azathioprine—multiple sclerosis	0.000766	0.00271	CcSEcCtD
Pasireotide—Arthralgia—Methylprednisolone—multiple sclerosis	0.000765	0.00271	CcSEcCtD
Pasireotide—Myalgia—Methylprednisolone—multiple sclerosis	0.000765	0.00271	CcSEcCtD
Pasireotide—Anxiety—Methylprednisolone—multiple sclerosis	0.000762	0.0027	CcSEcCtD
Pasireotide—Headache—Azathioprine—multiple sclerosis	0.000755	0.00267	CcSEcCtD
Pasireotide—Vertigo—Betamethasone—multiple sclerosis	0.000734	0.0026	CcSEcCtD
Pasireotide—Vertigo—Dexamethasone—multiple sclerosis	0.000734	0.0026	CcSEcCtD
Pasireotide—Insomnia—Prednisolone—multiple sclerosis	0.000723	0.00256	CcSEcCtD
Pasireotide—Alopecia—Prednisone—multiple sclerosis	0.000722	0.00256	CcSEcCtD
Pasireotide—Nausea—Azathioprine—multiple sclerosis	0.000716	0.00253	CcSEcCtD
Pasireotide—Hypertension—Dexamethasone—multiple sclerosis	0.000706	0.0025	CcSEcCtD
Pasireotide—Hypertension—Betamethasone—multiple sclerosis	0.000706	0.0025	CcSEcCtD
Pasireotide—Asthenia—Mitoxantrone—multiple sclerosis	0.000699	0.00247	CcSEcCtD
Pasireotide—Myalgia—Dexamethasone—multiple sclerosis	0.000696	0.00246	CcSEcCtD
Pasireotide—Myalgia—Betamethasone—multiple sclerosis	0.000696	0.00246	CcSEcCtD
Pasireotide—Anxiety—Betamethasone—multiple sclerosis	0.000693	0.00245	CcSEcCtD
Pasireotide—Anxiety—Dexamethasone—multiple sclerosis	0.000693	0.00245	CcSEcCtD
Pasireotide—Hypotension—Methylprednisolone—multiple sclerosis	0.000685	0.00243	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.00067	0.00237	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000668	0.00237	CcSEcCtD
Pasireotide—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000667	0.00236	CcSEcCtD
Pasireotide—Insomnia—Triamcinolone—multiple sclerosis	0.000665	0.00235	CcSEcCtD
Pasireotide—Insomnia—Methylprednisolone—multiple sclerosis	0.000663	0.00235	CcSEcCtD
Pasireotide—Anaemia—Prednisone—multiple sclerosis	0.000658	0.00233	CcSEcCtD
Pasireotide—Vertigo—Prednisone—multiple sclerosis	0.000639	0.00226	CcSEcCtD
Pasireotide—Fatigue—Triamcinolone—multiple sclerosis	0.000634	0.00224	CcSEcCtD
Pasireotide—Fatigue—Methylprednisolone—multiple sclerosis	0.000632	0.00224	CcSEcCtD
Pasireotide—Hypotension—Betamethasone—multiple sclerosis	0.000623	0.00221	CcSEcCtD
Pasireotide—Hypotension—Dexamethasone—multiple sclerosis	0.000623	0.00221	CcSEcCtD
Pasireotide—Vomiting—Mitoxantrone—multiple sclerosis	0.000619	0.00219	CcSEcCtD
Pasireotide—Hypertension—Prednisone—multiple sclerosis	0.000614	0.00218	CcSEcCtD
Pasireotide—Headache—Mitoxantrone—multiple sclerosis	0.00061	0.00216	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000608	0.00215	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000608	0.00215	CcSEcCtD
Pasireotide—Arthralgia—Prednisone—multiple sclerosis	0.000606	0.00215	CcSEcCtD
Pasireotide—Myalgia—Prednisone—multiple sclerosis	0.000606	0.00215	CcSEcCtD
Pasireotide—Anxiety—Prednisone—multiple sclerosis	0.000604	0.00214	CcSEcCtD
Pasireotide—Alopecia—Methotrexate—multiple sclerosis	0.000604	0.00214	CcSEcCtD
Pasireotide—Insomnia—Betamethasone—multiple sclerosis	0.000603	0.00214	CcSEcCtD
Pasireotide—Insomnia—Dexamethasone—multiple sclerosis	0.000603	0.00214	CcSEcCtD
Pasireotide—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.0006	0.00212	CcSEcCtD
Pasireotide—SSTR1—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.000594	0.00119	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—CCR1—multiple sclerosis	0.000586	0.00118	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—CXCL13—multiple sclerosis	0.000586	0.00118	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—TAGAP—multiple sclerosis	0.000582	0.00117	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—GPC5—multiple sclerosis	0.000582	0.00117	CbGpPWpGaD
Pasireotide—SSTR1—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000582	0.00117	CbGpPWpGaD
Pasireotide—Abdominal pain—Methylprednisolone—multiple sclerosis	0.00058	0.00205	CcSEcCtD
Pasireotide—Decreased appetite—Dexamethasone—multiple sclerosis	0.00058	0.00205	CcSEcCtD
Pasireotide—Decreased appetite—Betamethasone—multiple sclerosis	0.00058	0.00205	CcSEcCtD
Pasireotide—SSTR1—GPCR ligand binding—CCR5—multiple sclerosis	0.000579	0.00116	CbGpPWpGaD
Pasireotide—Nausea—Mitoxantrone—multiple sclerosis	0.000579	0.00205	CcSEcCtD
Pasireotide—Back pain—Methotrexate—multiple sclerosis	0.000575	0.00204	CcSEcCtD
Pasireotide—Fatigue—Betamethasone—multiple sclerosis	0.000575	0.00204	CcSEcCtD
Pasireotide—Fatigue—Dexamethasone—multiple sclerosis	0.000575	0.00204	CcSEcCtD
Pasireotide—SSTR1—Signaling Pathways—S1PR1—multiple sclerosis	0.000574	0.00115	CbGpPWpGaD
Pasireotide—SSTR5—GPCR ligand binding—CCL5—multiple sclerosis	0.00057	0.00114	CbGpPWpGaD
Pasireotide—SSTR3—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000564	0.00113	CbGpPWpGaD
Pasireotide—SSTR1—SIDS Susceptibility Pathways—TNF—multiple sclerosis	0.000559	0.00112	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—GPC5—multiple sclerosis	0.000558	0.00112	CbGpPWpGaD
Pasireotide—Anaemia—Methotrexate—multiple sclerosis	0.00055	0.00195	CcSEcCtD
Pasireotide—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000545	0.00193	CcSEcCtD
Pasireotide—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000545	0.00193	CcSEcCtD
Pasireotide—SSTR3—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000545	0.00109	CbGpPWpGaD
Pasireotide—SSTR1—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000541	0.00108	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—TAGAP—multiple sclerosis	0.000537	0.00108	CbGpPWpGaD
Pasireotide—Vertigo—Methotrexate—multiple sclerosis	0.000534	0.00189	CcSEcCtD
Pasireotide—SSTR3—Signaling by GPCR—CCL3—multiple sclerosis	0.000532	0.00107	CbGpPWpGaD
Pasireotide—SSTR3—GPCR downstream signaling—CCR2—multiple sclerosis	0.00053	0.00106	CbGpPWpGaD
Pasireotide—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000529	0.00187	CcSEcCtD
Pasireotide—Dizziness—Prednisolone—multiple sclerosis	0.000529	0.00187	CcSEcCtD
Pasireotide—Asthenia—Triamcinolone—multiple sclerosis	0.000527	0.00187	CcSEcCtD
Pasireotide—Abdominal pain—Betamethasone—multiple sclerosis	0.000527	0.00187	CcSEcCtD
Pasireotide—Abdominal pain—Dexamethasone—multiple sclerosis	0.000527	0.00187	CcSEcCtD
Pasireotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.000527	0.00106	CbGpPWpGaD
Pasireotide—Asthenia—Methylprednisolone—multiple sclerosis	0.000526	0.00186	CcSEcCtD
Pasireotide—SSTR2—GPCR ligand binding—CCL5—multiple sclerosis	0.000526	0.00106	CbGpPWpGaD
Pasireotide—Insomnia—Prednisone—multiple sclerosis	0.000525	0.00186	CcSEcCtD
Pasireotide—SSTR1—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000522	0.00105	CbGpPWpGaD
Pasireotide—Pruritus—Triamcinolone—multiple sclerosis	0.00052	0.00184	CcSEcCtD
Pasireotide—Pruritus—Methylprednisolone—multiple sclerosis	0.000519	0.00184	CcSEcCtD
Pasireotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000516	0.00103	CbGpPWpGaD
Pasireotide—SSTR5—GPCR ligand binding—CCR5—multiple sclerosis	0.000514	0.00103	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—PTGER4—multiple sclerosis	0.000512	0.00103	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—CCL3—multiple sclerosis	0.00051	0.00102	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—RGS1—multiple sclerosis	0.000509	0.00102	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—S1PR1—multiple sclerosis	0.000509	0.00102	CbGpPWpGaD
Pasireotide—SSTR1—GPCR downstream signaling—CCR2—multiple sclerosis	0.000508	0.00102	CbGpPWpGaD
Pasireotide—Myalgia—Methotrexate—multiple sclerosis	0.000506	0.00179	CcSEcCtD
Pasireotide—Arthralgia—Methotrexate—multiple sclerosis	0.000506	0.00179	CcSEcCtD
Pasireotide—Decreased appetite—Prednisone—multiple sclerosis	0.000505	0.00179	CcSEcCtD
Pasireotide—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000502	0.00178	CcSEcCtD
Pasireotide—Fatigue—Prednisone—multiple sclerosis	0.000501	0.00177	CcSEcCtD
Pasireotide—Headache—Prednisolone—multiple sclerosis	0.000501	0.00177	CcSEcCtD
Pasireotide—Constipation—Prednisone—multiple sclerosis	0.000497	0.00176	CcSEcCtD
Pasireotide—SSTR5—Signaling Pathways—GPC5—multiple sclerosis	0.000495	0.000993	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—CXCR3—multiple sclerosis	0.000495	0.000992	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—PTGER4—multiple sclerosis	0.000491	0.000985	CbGpPWpGaD
Pasireotide—SSTR3—GPCR downstream signaling—CNR1—multiple sclerosis	0.000489	0.000981	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—RGS1—multiple sclerosis	0.000488	0.000978	CbGpPWpGaD
Pasireotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.000487	0.000976	CbGpPWpGaD
Pasireotide—Dizziness—Triamcinolone—multiple sclerosis	0.000486	0.00172	CcSEcCtD
Pasireotide—Dizziness—Methylprednisolone—multiple sclerosis	0.000485	0.00172	CcSEcCtD
Pasireotide—SSTR3—Signaling Pathways—GPR65—multiple sclerosis	0.000482	0.000967	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—CCR2—multiple sclerosis	0.000481	0.000965	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000479	0.000962	CbGpPWpGaD
Pasireotide—Asthenia—Dexamethasone—multiple sclerosis	0.000479	0.00169	CcSEcCtD
Pasireotide—Asthenia—Betamethasone—multiple sclerosis	0.000479	0.00169	CcSEcCtD
Pasireotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000476	0.000955	CbGpPWpGaD
Pasireotide—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000475	0.00168	CcSEcCtD
Pasireotide—Nausea—Prednisolone—multiple sclerosis	0.000475	0.00168	CcSEcCtD
Pasireotide—SSTR1—Signaling by GPCR—CXCR3—multiple sclerosis	0.000474	0.000951	CbGpPWpGaD
Pasireotide—SSTR2—GPCR ligand binding—CCR5—multiple sclerosis	0.000474	0.000951	CbGpPWpGaD
Pasireotide—SSTR3—GPCR ligand binding—POMC—multiple sclerosis	0.000472	0.000947	CbGpPWpGaD
Pasireotide—Pruritus—Betamethasone—multiple sclerosis	0.000472	0.00167	CcSEcCtD
Pasireotide—Pruritus—Dexamethasone—multiple sclerosis	0.000472	0.00167	CcSEcCtD
Pasireotide—SSTR2—Signaling Pathways—S1PR1—multiple sclerosis	0.000469	0.000942	CbGpPWpGaD
Pasireotide—SSTR1—GPCR downstream signaling—CNR1—multiple sclerosis	0.000469	0.00094	CbGpPWpGaD
Pasireotide—Vomiting—Triamcinolone—multiple sclerosis	0.000467	0.00165	CcSEcCtD
Pasireotide—Vomiting—Methylprednisolone—multiple sclerosis	0.000466	0.00165	CcSEcCtD
Pasireotide—SSTR5—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000463	0.000929	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—GPR65—multiple sclerosis	0.000462	0.000927	CbGpPWpGaD
Pasireotide—SSTR3—GPCR ligand binding—CCL2—multiple sclerosis	0.000462	0.000927	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—CCR2—multiple sclerosis	0.000461	0.000925	CbGpPWpGaD
Pasireotide—Headache—Triamcinolone—multiple sclerosis	0.00046	0.00163	CcSEcCtD
Pasireotide—Headache—Methylprednisolone—multiple sclerosis	0.000459	0.00163	CcSEcCtD
Pasireotide—Abdominal pain—Prednisone—multiple sclerosis	0.000459	0.00163	CcSEcCtD
Pasireotide—SSTR2—SIDS Susceptibility Pathways—TNF—multiple sclerosis	0.000457	0.000917	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—GPC5—multiple sclerosis	0.000457	0.000916	CbGpPWpGaD
Pasireotide—Diarrhoea—Betamethasone—multiple sclerosis	0.000456	0.00162	CcSEcCtD
Pasireotide—Diarrhoea—Dexamethasone—multiple sclerosis	0.000456	0.00162	CcSEcCtD
Pasireotide—Hypotension—Methotrexate—multiple sclerosis	0.000454	0.00161	CcSEcCtD
Pasireotide—SSTR1—GPCR ligand binding—POMC—multiple sclerosis	0.000453	0.000908	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—CCL3—multiple sclerosis	0.000452	0.000907	CbGpPWpGaD
Pasireotide—SSTR1—SIDS Susceptibility Pathways—IL6—multiple sclerosis	0.000451	0.000904	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—CCR2—multiple sclerosis	0.00045	0.000904	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—CNR1—multiple sclerosis	0.000444	0.000891	CbGpPWpGaD
Pasireotide—SSTR1—GPCR ligand binding—CCL2—multiple sclerosis	0.000443	0.000888	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000442	0.000888	CbGpPWpGaD
Pasireotide—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000442	0.00157	CcSEcCtD
Pasireotide—SSTR3—Signaling Pathways—CXCL13—multiple sclerosis	0.000441	0.000885	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—CCR1—multiple sclerosis	0.000441	0.000885	CbGpPWpGaD
Pasireotide—Dizziness—Dexamethasone—multiple sclerosis	0.000441	0.00156	CcSEcCtD
Pasireotide—Dizziness—Betamethasone—multiple sclerosis	0.000441	0.00156	CcSEcCtD
Pasireotide—SSTR3—GPCR downstream signaling—CXCL10—multiple sclerosis	0.00044	0.000883	CbGpPWpGaD
Pasireotide—Insomnia—Methotrexate—multiple sclerosis	0.000439	0.00155	CcSEcCtD
Pasireotide—Nausea—Triamcinolone—multiple sclerosis	0.000437	0.00155	CcSEcCtD
Pasireotide—Nausea—Methylprednisolone—multiple sclerosis	0.000436	0.00154	CcSEcCtD
Pasireotide—SSTR5—Signaling by GPCR—PTGER4—multiple sclerosis	0.000435	0.000873	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—RGS1—multiple sclerosis	0.000433	0.000868	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000427	0.000857	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—CNR1—multiple sclerosis	0.000426	0.000854	CbGpPWpGaD
Pasireotide—Vomiting—Dexamethasone—multiple sclerosis	0.000424	0.0015	CcSEcCtD
Pasireotide—Vomiting—Betamethasone—multiple sclerosis	0.000424	0.0015	CcSEcCtD
Pasireotide—SSTR1—Signaling Pathways—CXCL13—multiple sclerosis	0.000423	0.000848	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—CCR1—multiple sclerosis	0.000423	0.000848	CbGpPWpGaD
Pasireotide—SSTR1—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000422	0.000847	CbGpPWpGaD
Pasireotide—Decreased appetite—Methotrexate—multiple sclerosis	0.000422	0.00149	CcSEcCtD
Pasireotide—SSTR5—Signaling by GPCR—CXCR3—multiple sclerosis	0.000421	0.000844	CbGpPWpGaD
Pasireotide—Fatigue—Methotrexate—multiple sclerosis	0.000418	0.00148	CcSEcCtD
Pasireotide—Headache—Dexamethasone—multiple sclerosis	0.000418	0.00148	CcSEcCtD
Pasireotide—Headache—Betamethasone—multiple sclerosis	0.000418	0.00148	CcSEcCtD
Pasireotide—SSTR2—Signaling by GPCR—CCL3—multiple sclerosis	0.000417	0.000837	CbGpPWpGaD
Pasireotide—Asthenia—Prednisone—multiple sclerosis	0.000417	0.00148	CcSEcCtD
Pasireotide—SSTR5—GPCR downstream signaling—CNR1—multiple sclerosis	0.000416	0.000834	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—CCR2—multiple sclerosis	0.000416	0.000834	CbGpPWpGaD
Pasireotide—Pruritus—Prednisone—multiple sclerosis	0.000411	0.00145	CcSEcCtD
Pasireotide—SSTR5—Signaling Pathways—GPR65—multiple sclerosis	0.00041	0.000822	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—CCR2—multiple sclerosis	0.000409	0.000821	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—PTGER4—multiple sclerosis	0.000402	0.000806	CbGpPWpGaD
Pasireotide—SSTR5—GPCR ligand binding—POMC—multiple sclerosis	0.000401	0.000805	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—CXCL10—multiple sclerosis	0.0004	0.000802	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—RGS1—multiple sclerosis	0.000399	0.000801	CbGpPWpGaD
Pasireotide—Diarrhoea—Prednisone—multiple sclerosis	0.000397	0.00141	CcSEcCtD
Pasireotide—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000397	0.00141	CcSEcCtD
Pasireotide—Nausea—Dexamethasone—multiple sclerosis	0.000396	0.0014	CcSEcCtD
Pasireotide—Nausea—Betamethasone—multiple sclerosis	0.000396	0.0014	CcSEcCtD
Pasireotide—SSTR5—GPCR ligand binding—CCL2—multiple sclerosis	0.000393	0.000788	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—CXCR3—multiple sclerosis	0.000388	0.000778	CbGpPWpGaD
Pasireotide—Dizziness—Prednisone—multiple sclerosis	0.000384	0.00136	CcSEcCtD
Pasireotide—Abdominal pain—Methotrexate—multiple sclerosis	0.000384	0.00136	CcSEcCtD
Pasireotide—SSTR2—GPCR downstream signaling—CNR1—multiple sclerosis	0.000384	0.00077	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—CXCL10—multiple sclerosis	0.000383	0.000769	CbGpPWpGaD
Pasireotide—SSTR3—GPCR downstream signaling—CCL5—multiple sclerosis	0.000379	0.00076	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—GPR65—multiple sclerosis	0.000378	0.000759	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—CNR1—multiple sclerosis	0.000378	0.000757	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—CCR2—multiple sclerosis	0.000378	0.000757	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CCR1—multiple sclerosis	0.000375	0.000752	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CXCL13—multiple sclerosis	0.000375	0.000752	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000374	0.000751	CbGpPWpGaD
Pasireotide—SSTR2—GPCR ligand binding—POMC—multiple sclerosis	0.00037	0.000743	CbGpPWpGaD
Pasireotide—Vomiting—Prednisone—multiple sclerosis	0.000369	0.00131	CcSEcCtD
Pasireotide—SSTR2—SIDS Susceptibility Pathways—IL6—multiple sclerosis	0.000369	0.00074	CbGpPWpGaD
Pasireotide—Headache—Prednisone—multiple sclerosis	0.000364	0.00129	CcSEcCtD
Pasireotide—SSTR1—GPCR downstream signaling—CCL5—multiple sclerosis	0.000363	0.000729	CbGpPWpGaD
Pasireotide—SSTR2—GPCR ligand binding—CCL2—multiple sclerosis	0.000362	0.000727	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—CNR1—multiple sclerosis	0.000348	0.000699	CbGpPWpGaD
Pasireotide—Asthenia—Methotrexate—multiple sclerosis	0.000348	0.00123	CcSEcCtD
Pasireotide—SSTR2—Signaling Pathways—CCR1—multiple sclerosis	0.000346	0.000694	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CXCL13—multiple sclerosis	0.000346	0.000694	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000345	0.000693	CbGpPWpGaD
Pasireotide—Nausea—Prednisone—multiple sclerosis	0.000345	0.00122	CcSEcCtD
Pasireotide—SSTR3—Signaling by GPCR—CCL5—multiple sclerosis	0.000344	0.00069	CbGpPWpGaD
Pasireotide—Pruritus—Methotrexate—multiple sclerosis	0.000343	0.00122	CcSEcCtD
Pasireotide—SSTR3—GPCR downstream signaling—CCR5—multiple sclerosis	0.000341	0.000685	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—CXCL10—multiple sclerosis	0.00034	0.000682	CbGpPWpGaD
Pasireotide—SSTR3—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000336	0.000675	CbGpPWpGaD
Pasireotide—Diarrhoea—Methotrexate—multiple sclerosis	0.000332	0.00118	CcSEcCtD
Pasireotide—SSTR1—Signaling by GPCR—CCL5—multiple sclerosis	0.00033	0.000662	CbGpPWpGaD
Pasireotide—SSTR1—GPCR downstream signaling—CCR5—multiple sclerosis	0.000327	0.000657	CbGpPWpGaD
Pasireotide—SSTR1—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000323	0.000647	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—CCL5—multiple sclerosis	0.000322	0.000646	CbGpPWpGaD
Pasireotide—Dizziness—Methotrexate—multiple sclerosis	0.000321	0.00114	CcSEcCtD
Pasireotide—SSTR3—Signaling Pathways—CCL3—multiple sclerosis	0.000314	0.00063	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—CXCL10—multiple sclerosis	0.000314	0.000629	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—CCR5—multiple sclerosis	0.00031	0.000622	CbGpPWpGaD
Pasireotide—Vomiting—Methotrexate—multiple sclerosis	0.000309	0.00109	CcSEcCtD
Pasireotide—SSTR3—Signaling by GPCR—IL2RA—multiple sclerosis	0.000306	0.000613	CbGpPWpGaD
Pasireotide—Headache—Methotrexate—multiple sclerosis	0.000304	0.00108	CcSEcCtD
Pasireotide—SSTR3—Signaling Pathways—PTGER4—multiple sclerosis	0.000302	0.000607	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—CCL3—multiple sclerosis	0.000301	0.000604	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—PGR—multiple sclerosis	0.000298	0.000598	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—CCL5—multiple sclerosis	0.000297	0.000596	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—CCR5—multiple sclerosis	0.000297	0.000596	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—IL2RA—multiple sclerosis	0.000293	0.000588	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—CCL5—multiple sclerosis	0.000293	0.000587	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—CXCR3—multiple sclerosis	0.000292	0.000586	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—CCR5—multiple sclerosis	0.00029	0.000582	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—PTGER4—multiple sclerosis	0.00029	0.000582	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—CD28—multiple sclerosis	0.000289	0.000581	CbGpPWpGaD
Pasireotide—Nausea—Methotrexate—multiple sclerosis	0.000288	0.00102	CcSEcCtD
Pasireotide—SSTR5—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000286	0.000574	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—PGR—multiple sclerosis	0.000286	0.000573	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—CCR2—multiple sclerosis	0.000284	0.00057	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—CXCR3—multiple sclerosis	0.00028	0.000562	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—CD28—multiple sclerosis	0.000277	0.000557	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—CCR2—multiple sclerosis	0.000272	0.000547	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—CCL5—multiple sclerosis	0.00027	0.000542	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—CCR5—multiple sclerosis	0.000268	0.000537	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CCL3—multiple sclerosis	0.000267	0.000536	CbGpPWpGaD
Pasireotide—SSTR3—GPCR downstream signaling—POMC—multiple sclerosis	0.000267	0.000535	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000264	0.00053	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—CCR5—multiple sclerosis	0.000264	0.000529	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—CNR1—multiple sclerosis	0.000262	0.000526	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—IL2RA—multiple sclerosis	0.00026	0.000521	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—PTGER4—multiple sclerosis	0.000257	0.000516	CbGpPWpGaD
Pasireotide—SSTR1—GPCR downstream signaling—POMC—multiple sclerosis	0.000256	0.000513	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—PGR—multiple sclerosis	0.000253	0.000508	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—CNR1—multiple sclerosis	0.000251	0.000504	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CXCR3—multiple sclerosis	0.000248	0.000498	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CCL3—multiple sclerosis	0.000247	0.000495	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CD28—multiple sclerosis	0.000246	0.000494	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—CCR5—multiple sclerosis	0.000243	0.000488	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—POMC—multiple sclerosis	0.000242	0.000486	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CCR2—multiple sclerosis	0.000242	0.000485	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—IL2RA—multiple sclerosis	0.00024	0.000481	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—PTGER4—multiple sclerosis	0.000237	0.000476	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—CCL2—multiple sclerosis	0.000237	0.000476	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—CXCL10—multiple sclerosis	0.000236	0.000474	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—PGR—multiple sclerosis	0.000234	0.000469	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—POMC—multiple sclerosis	0.000232	0.000466	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CXCR3—multiple sclerosis	0.000229	0.00046	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—CCL2—multiple sclerosis	0.000227	0.000456	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CD28—multiple sclerosis	0.000227	0.000456	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—POMC—multiple sclerosis	0.000227	0.000455	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—CXCL10—multiple sclerosis	0.000226	0.000454	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CNR1—multiple sclerosis	0.000223	0.000447	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CCR2—multiple sclerosis	0.000223	0.000447	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—TYK2—multiple sclerosis	0.000215	0.000432	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—POMC—multiple sclerosis	0.000209	0.00042	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—CD86—multiple sclerosis	0.000206	0.000414	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—TYK2—multiple sclerosis	0.000206	0.000414	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—POMC—multiple sclerosis	0.000206	0.000413	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CNR1—multiple sclerosis	0.000206	0.000413	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—CCL5—multiple sclerosis	0.000203	0.000408	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—CCL2—multiple sclerosis	0.000202	0.000404	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CXCL10—multiple sclerosis	0.000201	0.000403	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—CD86—multiple sclerosis	0.000198	0.000397	CbGpPWpGaD
Pasireotide—SSTR3—GPCR downstream signaling—IL2—multiple sclerosis	0.000197	0.000396	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—CCL5—multiple sclerosis	0.000195	0.000391	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—POMC—multiple sclerosis	0.00019	0.000381	CbGpPWpGaD
Pasireotide—SSTR1—GPCR downstream signaling—IL2—multiple sclerosis	0.000189	0.000379	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—SPP1—multiple sclerosis	0.000188	0.000378	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—CCL2—multiple sclerosis	0.000186	0.000373	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CXCL10—multiple sclerosis	0.000185	0.000372	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—CCR5—multiple sclerosis	0.000183	0.000367	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—TYK2—multiple sclerosis	0.000183	0.000367	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—IL2RA—multiple sclerosis	0.00018	0.000362	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—SPP1—multiple sclerosis	0.00018	0.000362	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—IL2—multiple sclerosis	0.000179	0.000359	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—CCR5—multiple sclerosis	0.000176	0.000352	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CD86—multiple sclerosis	0.000176	0.000352	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—IL2RA—multiple sclerosis	0.000173	0.000347	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CCL5—multiple sclerosis	0.000173	0.000347	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—IL2—multiple sclerosis	0.000172	0.000344	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—TYK2—multiple sclerosis	0.000169	0.000339	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—IL2—multiple sclerosis	0.000168	0.000336	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—APOE—multiple sclerosis	0.000167	0.000334	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CD86—multiple sclerosis	0.000162	0.000325	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—SPP1—multiple sclerosis	0.00016	0.000321	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—APOE—multiple sclerosis	0.00016	0.00032	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CCL5—multiple sclerosis	0.00016	0.00032	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CCR5—multiple sclerosis	0.000156	0.000312	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—IL2—multiple sclerosis	0.000155	0.00031	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—IL2RA—multiple sclerosis	0.000153	0.000308	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—IL2—multiple sclerosis	0.000152	0.000306	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—CD80—multiple sclerosis	0.000151	0.000302	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—SPP1—multiple sclerosis	0.000148	0.000296	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—CD80—multiple sclerosis	0.000144	0.00029	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CCR5—multiple sclerosis	0.000144	0.000288	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—POMC—multiple sclerosis	0.000143	0.000287	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—APOE—multiple sclerosis	0.000142	0.000284	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—IL2RA—multiple sclerosis	0.000142	0.000284	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—IL2—multiple sclerosis	0.000141	0.000282	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—CCL2—multiple sclerosis	0.00014	0.000281	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—POMC—multiple sclerosis	0.000137	0.000275	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—MAPK1—multiple sclerosis	0.000137	0.000275	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—CCL2—multiple sclerosis	0.000134	0.000269	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—MAPK1—multiple sclerosis	0.000131	0.000264	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—APOE—multiple sclerosis	0.000131	0.000262	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CD80—multiple sclerosis	0.000128	0.000257	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—TYK2—multiple sclerosis	0.000127	0.000255	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—TYK2—multiple sclerosis	0.000122	0.000245	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—POMC—multiple sclerosis	0.000122	0.000244	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CCL2—multiple sclerosis	0.000119	0.000239	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CD80—multiple sclerosis	0.000118	0.000237	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—MAPK1—multiple sclerosis	0.000117	0.000234	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—POMC—multiple sclerosis	0.000112	0.000225	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CCL2—multiple sclerosis	0.00011	0.00022	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—TYK2—multiple sclerosis	0.000108	0.000217	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—MAPK1—multiple sclerosis	0.000108	0.000216	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—IL2—multiple sclerosis	0.000106	0.000212	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—IL6—multiple sclerosis	0.000105	0.000211	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—IL2—multiple sclerosis	0.000101	0.000203	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—IL6—multiple sclerosis	0.000101	0.000202	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—MMP9—multiple sclerosis	0.0001	0.000201	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—TYK2—multiple sclerosis	9.98e-05	0.0002	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—MMP9—multiple sclerosis	9.6e-05	0.000193	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—IL2—multiple sclerosis	9e-05	0.00018	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—IL6—multiple sclerosis	8.95e-05	0.00018	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—STAT3—multiple sclerosis	8.9e-05	0.000179	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—STAT3—multiple sclerosis	8.54e-05	0.000171	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—MMP9—multiple sclerosis	8.52e-05	0.000171	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—IL2—multiple sclerosis	8.3e-05	0.000167	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—MYC—multiple sclerosis	8.27e-05	0.000166	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—IL6—multiple sclerosis	8.26e-05	0.000166	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—TGFB1—multiple sclerosis	8.25e-05	0.000166	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—MAPK1—multiple sclerosis	8.09e-05	0.000162	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—MYC—multiple sclerosis	7.93e-05	0.000159	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—TGFB1—multiple sclerosis	7.91e-05	0.000159	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—MMP9—multiple sclerosis	7.86e-05	0.000158	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—MAPK1—multiple sclerosis	7.76e-05	0.000156	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—STAT3—multiple sclerosis	7.57e-05	0.000152	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—MYC—multiple sclerosis	7.04e-05	0.000141	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—TGFB1—multiple sclerosis	7.02e-05	0.000141	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—STAT3—multiple sclerosis	6.99e-05	0.00014	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—MAPK1—multiple sclerosis	6.88e-05	0.000138	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—MYC—multiple sclerosis	6.49e-05	0.00013	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—TGFB1—multiple sclerosis	6.48e-05	0.00013	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—MAPK1—multiple sclerosis	6.35e-05	0.000127	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—IL6—multiple sclerosis	6.22e-05	0.000125	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—IL6—multiple sclerosis	5.96e-05	0.00012	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—IL6—multiple sclerosis	5.29e-05	0.000106	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—IL6—multiple sclerosis	4.88e-05	9.79e-05	CbGpPWpGaD
